Info@ThinkPinkRocks.com

GSK starts shipping FLUARIX QUADRIVALENT (Influenza Vaccine) to US healthcare providers

GSK announced today it has begun shipping FLUARIX QUADRIVALENT (Influenza Vaccine) doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research.

Continued here:
GSK starts shipping FLUARIX QUADRIVALENT (Influenza Vaccine) to US healthcare providers

Share

Leave a Reply

Solve : *
5 + 21 =